The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration
The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
CerTest Biotec uses the BD MAX molecular diagnostic system open system reagent suite to develop RT-PCR detection kit
Subscribe To Our Newsletter & Stay Updated
